Chung Sun-Ku, Lee Min-Goo, Ryu Byung-Kyu, Lee Jin-Hee, Han Jikhyon, Byun Do-Sun, Chae Kwon-Seok, Lee Kil Yeon, Jang Jae-Young, Kim Hyo-Jong, Chi Sung-Gil
School of Life Sciences and Biotechnology, Korea University, Seoul, Korea.
Gastroenterology. 2007 Jun;132(7):2459-77. doi: 10.1053/j.gastro.2007.04.024. Epub 2007 Apr 15.
BACKGROUND & AIMS: X-linked inhibitor of apoptosis protein-associated factor 1 (XAF1) is a candidate tumor suppressor located at the chromosome 17p13 region, but the molecular basis underlying its inactivation in human tumors and growth-inhibiting function has not been well defined. We explored the candidacy of XAF1 as a suppressor in colorectal tumorigenesis.
XAF1 expression was characterized by polymerase chain reaction-based cloning, isoform-specific polymerase chain reaction, ribonuclease protection, and immunoblot assays. Allelic loss of the gene was evaluated by loss of heterozygosity (LOH) assay, and promoter CG dinucleotide (CpG) site methylation was determined using bisulfite sequencing. The effect of XAF1 on tumor growth was examined using flow cytometry, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling, colony formation, and viability assays.
Expression of 5 XAF1 variants including 2 novel transcripts was down-regulated concomitantly in 11 of 20 (55%) cell lines and 26 of 65 (40%) primary tumors. XAF1 reduction was tumor-specific and showed a correlation with advanced stage and high grade of tumor. LOH of the gene was found in 12 of 33 (36%) tumors. Promoter CpG site methylation was observed frequently in both cell lines and tumor tissues including many LOH tumors, suggesting that biallelic inactivation of XAF1 might be common in colorectal cancers. XAF1 expression suppressed tumor cell growth and enhanced cellular response to various apoptotic stimuli, such as 5-fluorouracil, etoposide, H(2)O(2), gamma-irradiation, ultraviolet, and tumor necrosis factor-alpha, whereas knockdown of its expression protected cells from the stresses.
Genetic and epigenetic alteration of XAF1 is a common event in colorectal tumorigenesis and contributes to the malignant tumor progression by providing survival advantages for tumor cells under various stress conditions.
X连锁凋亡抑制蛋白相关因子1(XAF1)是一种位于17号染色体p13区域的候选肿瘤抑制因子,但其在人类肿瘤中失活的分子基础及其生长抑制功能尚未完全明确。我们探讨了XAF1作为结直肠癌发生抑制因子的可能性。
通过基于聚合酶链反应的克隆、异构体特异性聚合酶链反应、核糖核酸酶保护和免疫印迹分析来表征XAF1的表达。通过杂合性缺失(LOH)分析评估该基因的等位基因缺失,并使用亚硫酸氢盐测序确定启动子CG二核苷酸(CpG)位点甲基化。使用流式细胞术、末端脱氧核苷酸转移酶介导的脱氧尿苷三磷酸缺口末端标记、集落形成和活力分析来检测XAF1对肿瘤生长的影响。
在20个细胞系中的11个(55%)和65个原发性肿瘤中的26个(40%)中,包括2种新转录本在内的5种XAF1变体的表达同时下调。XAF1表达降低具有肿瘤特异性,且与肿瘤晚期和高分级相关。在33个肿瘤中的12个(36%)中发现了该基因的LOH。在细胞系和肿瘤组织中均频繁观察到启动子CpG位点甲基化,包括许多LOH肿瘤,这表明XAF1的双等位基因失活在结直肠癌中可能很常见。XAF1表达抑制肿瘤细胞生长,并增强细胞对各种凋亡刺激的反应,如5-氟尿嘧啶、依托泊苷、H₂O₂、γ射线、紫外线和肿瘤坏死因子-α,而敲低其表达则使细胞免受这些应激的影响。
XAF1的遗传和表观遗传改变是结直肠癌发生中的常见事件,并通过在各种应激条件下为肿瘤细胞提供生存优势而促进恶性肿瘤进展。